Robert Tadevosyan: A Week of Science, Collaboration, and Growth at ISTH 2026
Robert Tadevosyan, Head Assistant of Scientific Communities at YSMU Student’s Scientific Society, Volunteer Publishing Editor at Hemostasis Today, shared a post on LinkedIn:
”Still thinking about what an amazing week International Society on Thrombosis and Haemostasis (ISTH) 2026 was.
These five days were filled with learning, inspiring conversations, and meeting incredible people from all over the world.
I was proud to present our poster, which describes what is, to the best of our knowledge, the first reported case of the coexistence of von Willebrand disease, β-thalassemia, an MEFV gene mutation, and platelet aggregation defects in a single patient.
It was exciting to share our findings, discuss this unique case with colleagues, and receive valuable feedback.
A huge thank you to my scientific supervisor Heghine Khachatryan for the constant support, guidance, and encouragement. I wouldn’t have had this opportunity without your mentorship.
Thank you to my senior friends Anna Stepanyan, Elen Avetisyan, Hemine Sayiyan, who were always there to help, answer my questions, and support me along the way.
A special thank you to my two friends and co-authors Samvel Avetisyan and Adriana Davtyan. This work would not have been possible without your collaboration, support, and countless discussions throughout the research process.
And of course, a little thank you to Paris. Between the busy congress days, it was wonderful to walk through such a beautiful city, enjoy its atmosphere, and create memories that I’ll always carry with me.
After these inspiring five days, I feel full of new ideas, motivation, and excitement for the future.
ISTH2026 gave me not only new knowledge and connections but also a fresh perspective on research and the importance of continuous learning.
I’m excited to take these experiences forward and continue growing in this field.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions